Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
Elevated blood neurofilament light chain (NfL), which indicates the loss of neuronal integrity, is increasingly implicated as a diagnostic and outcome-predicting biomarker for neurological diseases. However, its diagnostic implication for Parkinson’s disease (PD) remains unclear, with conflicting da...
Guardado en:
Autores principales: | Jia-Hung Chen, Lung Chan, Chen-Chih Chung, Oluwaseun Adebayo Bamodu, Chien-Tai Hong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fcdef5c660774b09aa6ccafab1413148 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Kuo-Hsuan Chang, et al.
Publicado: (2021) -
Neurofilament Light Chain Is a Promising Biomarker in Alcohol Dependence
por: Yanfei Li, et al.
Publicado: (2021) -
Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders
por: Elena Diekämper, et al.
Publicado: (2021) -
Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
por: Marta Simone, et al.
Publicado: (2021) -
Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
por: Cai L, et al.
Publicado: (2018)